Jennifer Horton, NP
Nurse Practitioner · Washington
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 16 years
- Graduated 2010
Offices
3 locations · Medstar Medical Group II LLC · 3,726 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jennifer Horton’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$23,088
Medicare paid this office $23,088 for 193 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 127 | $8,505 | $51 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 23 | $5,003 | $33 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 19 | $3,398 | $31 |
| Return visit (30+ min) | 36 | $2,565 | $69 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 22 | $2,333 | $26 |
See all 6 services
| Short return visit (20+ min) | 127 | $8,505 | $51 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 23 | $5,003 | $33 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 19 | $3,398 | $31 |
| Return visit (30+ min) | 36 | $2,565 | $69 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 22 | $2,333 | $26 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $961 | $53 |
Who their Medicare patients are
193 Original Medicare patients in 2024. Average age 70 · Under 65 16% · 85 and older 6% · Women 73% · Also on Medicaid 16% · Health risk score 1.02. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 29% · Coronary heart disease 27% · Depression 21% · Chronic kidney disease 19% · COPD 18% · Heart failure 11% · Cancer 11% · Atrial fibrillation 11% · Stroke 8%.
The office billed $101,604, Medicare allowed $33,414 and paid $23,088; for 577 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 193 | 577 | 70 | 1.02 | $101,604 | $23,088 |
| 2023 | 192 | 448 | 71 | 0.83 | $83,154 | $18,837 |
| 2022 | 179 | 363 | 70 | 0.91 | $66,591 | $18,592 |
| 2021 | 81 | 139 | 67 | 1.22 | $30,942 | $7,733 |
| 2020 | 148 | 517 | 67 | 1.24 | $112,216 | $33,391 |
| 2019 | 112 | 442 | 65 | 1.21 | $85,438 | $27,410 |
| 2018 | 205 | 429 | 68 | 1.07 | $73,259 | $22,943 |
| 2017 | 196 | 366 | 71 | 1.22 | $60,496 | $20,610 |
| 2016 | 12 | 18 | 69 | 0.94 | $2,382 | $929 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Short return visit (20+ min) | 122 | $8,442 | $53 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 15 | $2,908 | $32 |
| Return visit (30+ min) | 49 | $2,346 | $48 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 13 | $2,108 | $34 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 14 | $1,768 | $27 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $838 | $60 |
2022: 4 services
| Short return visit (20+ min) | 119 | $8,016 | $64 |
| Return visit (30+ min) | 47 | $4,035 | $84 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 16 | $2,804 | $36 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 16 | $1,835 | $29 |
2021: 3 services
| Return visit (30+ min) | 61 | $4,450 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,486 | $114 |
| Short return visit (20+ min) | 11 | $344 | $31 |
2020: 10 services
| Return visit (30+ min) | 98 | $10,831 | $66 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 81 | $8,583 | $106 |
| Short return visit (20+ min) | 48 | $3,451 | $48 |
| New patient visit (45+ min) | 20 | $2,174 | $109 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,048 | $50 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $979 | $70 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 15 | $915 | $61 |
| Administration of influenza virus vaccine | 20 | $381 | $18 |
| Administration of pneumococcal vaccine | 15 | $272 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $139 | $8 |
2019: 8 services
| Return visit (30+ min) | 90 | $12,199 | $69 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 56 | $5,890 | $105 |
| New patient visit (45+ min) | 17 | $1,780 | $105 |
| Short return visit (20+ min) | 22 | $1,501 | $50 |
| Influenza vaccine, inactivated | 13 | $758 | $58 |
| Administration of influenza virus vaccine | 19 | $339 | $18 |
| Administration of pneumococcal vaccine | 12 | $214 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $199 | $11 |
2018: 9 services
| Return visit (30+ min) | 81 | $7,768 | $74 |
| New patient visit (45+ min) | 45 | $4,024 | $89 |
| Long return visit (40+ min) | 37 | $3,447 | $86 |
| Short return visit (20+ min) | 59 | $3,170 | $46 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 27 | $298 | $11 |
| Detection test by immunoassay with direct visual observation for influenza virus | 18 | $294 | $15 |
| Inhalation treatment for airway obstruction or sputum production | 21 | $279 | $12 |
| Administration of pneumococcal vaccine | 12 | $259 | $22 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 20 | $2 | None |
2017: 9 services
| New patient visit (45+ min) | 60 | $6,378 | $106 |
| Long return visit (40+ min) | 41 | $4,170 | $99 |
| New patient visit (30+ min) | 57 | $4,167 | $73 |
| Return visit (30+ min) | 31 | $2,469 | $77 |
| Short return visit (20+ min) | 35 | $1,892 | $50 |
| Detection test by immunoassay with direct visual observation for influenza virus | 13 | $258 | $16 |
| Inhalation treatment for airway obstruction or sputum production | 16 | $219 | $14 |
| Automated urinalysis test | 21 | $66 | $3 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 19 | $2 | None |
Medicaid work
$10,297 in 2024
Medicaid paid $10,297 for 130 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 130 | $10,297 |
| 2024 | 130 | 1 | 25 | $10,297 |
| 2023 | 148 | 1 | 26 | $12,676 |
| 2022 | 85 | 1 | 20 | $6,852 |
| 2021 | 139 | 2 | 35 | $13,337 |
| 2020 | 453 | 3 | 36 | $37,113 |
| 2019 | 464 | 5 | 40 | $12,986 |
| 2018 | 591 | 6 | 43 | $93 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 148 | $12,676 |
2022
| Short return visit (20+ min) | 85 | $6,852 |
2021
| Return visit (30+ min) | 113 | $11,510 |
| Short return visit (20+ min) | 26 | $1,827 |
2020
| Return visit (30+ min) | 248 | $24,226 |
| Short return visit (20+ min) | 191 | $12,654 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 14 | $233 |
2019
| Return visit (30+ min) | 330 | $10,113 |
| New patient visit (45+ min) | 12 | $1,827 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 31 | $547 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 60 | $350 |
| Short return visit (20+ min) | 31 | $148 |
2018
| Return visit (30+ min) | 249 | $93 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 53 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 18 | $0 |
| New patient visit (45+ min) | 74 | $0 |
| Short return visit (20+ min) | 124 | $0 |
| Long return visit (40+ min) | 73 | $0 |
Drugs they prescribed that Part D paid
$9,966
Pharmacies billed $9,966 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 397) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
334 generic and 51 brand-name prescriptions · $9,966 in drug cost · 150 antibiotic prescriptions to 117 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Paxlovid | 22 | $1,429 | $65 |
| Fluticasone Propionate | 47 | $499 | $10 |
| Albuterol Sulfate Hfa | 16 | $440 | $26 |
| Doxycycline Hyclate | 31 | $262 | $7 |
| Cefdinir | 13 | $215 | $15 |
See all 10 drugs
| Paxlovid | 22 | $1,429 | $65 |
| Fluticasone Propionate | 47 | $499 | $10 |
| Albuterol Sulfate Hfa | 16 | $440 | $26 |
| Doxycycline Hyclate | 31 | $262 | $7 |
| Cefdinir | 13 | $215 | $15 |
| Azithromycin | 33 | $185 | $5 |
| Methylprednisolone | 20 | $125 | $6 |
| Nitrofurantoin Mono-Macro | 19 | $113 | $6 |
| Amoxicillin-Clavulanate Potass | 13 | $91 | $7 |
| Prednisone | 12 | $20 | $2 |
Year by year
| 2024 | 397 | 207 | 0% (0) | 13% | $9,966 |
| 2023 | 358 | 180 | None | 10% | $8,714 |
| 2022 | 398 | 202 | None | 12% | $33,361 |
| 2021 | 1,350 | 189 | None | None | $115,863 |
| 2020 | 1,647 | 174 | None | None | $172,891 |
| 2019 | 1,173 | 132 | None | None | $115,054 |
| 2018 | 519 | 143 | None | None | $51,345 |
| 2017 | 218 | 115 | 6% (12) | 11% | $4,453 |
| 2016 | 161 | 85 | None | 9% | $3,077 |
| 2015 | 55 | 38 | 0% (0) | None | $598 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Lagevrio (Eua) | 16 | $1,192 | $74 |
| Fluticasone Propionate | 61 | $724 | $12 |
| Albuterol Sulfate Hfa | 20 | $623 | $31 |
| Doxycycline Hyclate | 35 | $489 | $14 |
| Paxlovid (Eua) | 29 | $299 | $10 |
| Methylprednisolone | 31 | $298 | $10 |
| Nitrofurantoin Mono-Macro | 13 | $149 | $11 |
| Amoxicillin-Clavulanate Potass | 12 | $131 | $11 |
| Azithromycin | 18 | $122 | $7 |
2022: 6 drugs
| Doxycycline Hyclate | 33 | $601 | $18 |
| Fluticasone Propionate | 49 | $459 | $9 |
| Paxlovid (Eua) | 38 | $402 | $11 |
| Lagevrio (Eua) | 16 | $173 | $11 |
| Methylprednisolone | 23 | $160 | $7 |
| Azithromycin | 17 | $106 | $6 |
2021: 30 drugs
| Spiriva Respimat | 11 | $4,843 | $440 |
| Atorvastatin | 118 | $1,791 | $15 |
| Ezetimibe | 11 | $1,402 | $127 |
| Levothyroxine | 58 | $1,278 | $22 |
| Duloxetine | 20 | $1,269 | $63 |
| Metoprolol | 36 | $754 | $21 |
| Bupropion Xl | 12 | $730 | $61 |
| Losartan | 33 | $696 | $21 |
| Albuterol Sulfate Hfa | 12 | $658 | $55 |
| Montelukast | 23 | $546 | $24 |
| Omeprazole | 17 | $501 | $29 |
| Pantoprazole | 22 | $412 | $19 |
| Fluticasone Propionate | 21 | $394 | $19 |
| Rosuvastatin | 12 | $392 | $33 |
| Pravastatin | 14 | $384 | $27 |
| Trazodone | 39 | $379 | $10 |
| Amlodipine Besylate | 64 | $365 | $6 |
| Lisinopril | 52 | $299 | $6 |
| Gabapentin | 11 | $268 | $24 |
| Escitalopram | 11 | $248 | $23 |
| Metformin | 30 | $244 | $8 |
| Hydrochlorothiazide | 47 | $212 | $5 |
| Metoprolol | 26 | $191 | $7 |
| Simvastatin | 24 | $190 | $8 |
| Carvedilol | 11 | $176 | $16 |
| Ibuprofen | 16 | $164 | $10 |
| Atenolol | 13 | $146 | $11 |
| Sertraline | 24 | $144 | $6 |
| Glimepiride | 13 | $134 | $10 |
| Alendronate | 13 | $108 | $8 |
2020: 51 drugs
| Tradjenta | 22 | $19,391 | $881 |
| Xarelto | 13 | $8,744 | $673 |
| Combivent Respimat | 14 | $6,167 | $441 |
| Spiriva Respimat | 12 | $5,425 | $452 |
| Breo Ellipta | 12 | $4,452 | $371 |
| Duloxetine | 38 | $2,406 | $63 |
| Ezetimibe | 13 | $2,113 | $163 |
| Fluoxetine | 25 | $1,721 | $69 |
| Levothyroxine | 72 | $1,637 | $23 |
| Atorvastatin | 93 | $1,551 | $17 |
| Buspirone | 11 | $1,215 | $110 |
| Bupropion Xl | 14 | $1,145 | $82 |
| Nifedipine Er | 19 | $1,113 | $59 |
| Metoprolol | 35 | $999 | $29 |
| Ventolin Hfa | 15 | $868 | $58 |
| Esomeprazole Magnesium | 17 | $745 | $44 |
| Baclofen | 16 | $704 | $44 |
| Amlodipine Besylate | 82 | $640 | $8 |
| Diclofenac | 15 | $612 | $41 |
| Losartan | 38 | $599 | $16 |
| Gabapentin | 24 | $580 | $24 |
| Fluticasone Propionate | 23 | $549 | $24 |
| Rosuvastatin | 15 | $505 | $34 |
| Albuterol Sulfate Hfa | 11 | $497 | $45 |
| Lisinopril | 51 | $497 | $10 |
| Escitalopram | 16 | $480 | $30 |
| Trazodone | 32 | $444 | $14 |
| Donepezil | 13 | $421 | $32 |
| Ibuprofen | 31 | $400 | $13 |
| Montelukast | 15 | $293 | $20 |
| Tizanidine | 16 | $272 | $17 |
| Simvastatin | 25 | $265 | $11 |
| Clonidine | 14 | $253 | $18 |
| Nitrofurantoin Mono-Macro | 12 | $247 | $21 |
| Clopidogrel | 16 | $244 | $15 |
| Hydrochlorothiazide | 48 | $233 | $5 |
| Omeprazole | 30 | $231 | $8 |
| Metformin Hcl Er | 25 | $227 | $9 |
| Metformin | 23 | $205 | $9 |
| Alprazolam | 18 | $203 | $11 |
| Glimepiride | 14 | $201 | $14 |
| Carvedilol | 16 | $192 | $12 |
| Metoprolol | 19 | $161 | $8 |
| Hydroxyzine | 11 | $148 | $13 |
| Sertraline | 15 | $148 | $10 |
| Atenolol | 11 | $139 | $13 |
| Methylprednisolone | 11 | $118 | $11 |
| Zolpidem | 14 | $114 | $8 |
| Glipizide | 12 | $99 | $8 |
| Triamcinolone Acetonide | 11 | $75 | $7 |
| Pantoprazole | 11 | $74 | $7 |
2019: 34 drugs
| Combivent Respimat | 14 | $5,683 | $406 |
| Breo Ellipta | 12 | $4,240 | $353 |
| Ezetimibe | 12 | $2,157 | $180 |
| Divalproex Sodium Er | 11 | $1,838 | $167 |
| Levothyroxine | 65 | $1,242 | $19 |
| Ventolin Hfa | 14 | $1,206 | $86 |
| Duloxetine | 24 | $1,016 | $42 |
| Diclofenac | 14 | $942 | $67 |
| Fenofibrate | 23 | $870 | $38 |
| Gabapentin | 29 | $803 | $28 |
| Albuterol Sulfate Hfa | 13 | $724 | $56 |
| Metoprolol | 14 | $649 | $46 |
| Atorvastatin | 37 | $602 | $16 |
| Fluoxetine | 24 | $485 | $20 |
| Escitalopram | 15 | $425 | $28 |
| Amlodipine Besylate | 53 | $415 | $8 |
| Cyclobenzaprine | 19 | $338 | $18 |
| Lisinopril | 37 | $335 | $9 |
| Fluticasone Propionate | 26 | $318 | $12 |
| Metformin Hcl Er | 19 | $296 | $16 |
| Bupropion Xl | 12 | $269 | $22 |
| Trazodone | 13 | $253 | $19 |
| Omeprazole | 19 | $228 | $12 |
| Losartan | 19 | $177 | $9 |
| Metoprolol | 14 | $158 | $11 |
| Simvastatin | 14 | $155 | $11 |
| Glimepiride | 11 | $151 | $14 |
| Spironolactone | 11 | $149 | $14 |
| Tizanidine | 11 | $124 | $11 |
| Alprazolam | 25 | $103 | $4 |
| Hydrochlorothiazide | 24 | $93 | $4 |
| Glipizide | 12 | $85 | $7 |
| Metformin | 14 | $76 | $5 |
| Zolpidem | 11 | $60 | $5 |
2018: 10 drugs
| Ventolin Hfa | 16 | $886 | $55 |
| Duloxetine | 12 | $363 | $30 |
| Levothyroxine | 17 | $265 | $16 |
| Methylprednisolone | 23 | $263 | $11 |
| Gabapentin | 14 | $259 | $18 |
| Fluticasone Propionate | 19 | $227 | $12 |
| Doxycycline Hyclate | 13 | $207 | $16 |
| Lisinopril | 18 | $123 | $7 |
| Losartan | 11 | $110 | $10 |
| Amlodipine Besylate | 14 | $101 | $7 |
2017: 3 drugs
| Methylprednisolone | 32 | $461 | $14 |
| Fluticasone Propionate | 21 | $194 | $9 |
| Azithromycin | 16 | $110 | $7 |
2016: 1 drug
| Azithromycin | 15 | $118 | $8 |
Money from drug and device companies
$35 in 2024
| 2024 | 1 | 2 | None | $35 |
| 2023 | 1 | 1 | None | $27 |
| 2022 | 8 | 12 | None | $199 |
| 2021 | 10 | 16 | None | $265 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $35 | 2 payments
|
See all 2 published payments
| Abbvie | Meals · 2024-07-15 | Vraylar | $18 |
| Abbvie | Meals · 2024-03-11 | Vraylar | $17 |
See earlier years (2023, 2022, 2021)
2023: $27
| Abbvie | Ubrelvy | $27 | 1 payment
|
2022: $199
| Abbvie | Vraylar | $33 | 2 payments
|
| Daiichi Sankyo | Injectafer | $32 | 2 payments
|
| Novo Nordisk | Rybelsus | $30 | 2 payments
|
| Sanofi-Aventis U.S. | Toujeo | $27 | 2 payments
|
| Amgen | Otezla | $24 | 1 payment
|
| Merck Sharp & Dohme | Belsomra | $22 | 1 payment
|
| Lilly USA | Trulicity | $16 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $14 | 1 payment
|
2021: $265
| AstraZeneca Pharmaceuticals LP | Breztri | $44 | 3 payments
|
| Sunovion Pharmaceuticals | Gemtesa | $43 | 3 payments
|
| Lilly USA | Trulicity | $33 | 2 payments
|
| AbbVie | Ubrelvy | $33 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $25 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 2 | $24 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $19 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $18 | 1 payment
|
| Novo Nordisk | Ozempic | $15 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1710299474
- Licence
- CA 95001953
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 1375 Blossom Hill Rd, San Jose, CA, 95118
- NPI first listed
- 2010-07-10
- NPI last updated
- 2015-08-27
This is when the NPI record was last certified, not a medical board exam.